Skip to main content
. 2021 Jun 17;65(7):e00413-21. doi: 10.1128/AAC.00413-21

TABLE 1.

Median (n = 3) MICSCFM2 of tobramycin (μg/ml) for the different P. aeruginosa PAO1 lineages

Lineage + treatmenta Cycle 0 Cycle 5 Cycle 10 Cycle 16
L1 TOB 10 10 20 40
L2 TOB 10 10 10 40
L3 TOB 10 10 40 40
L1 TOB + C-30 10 40 40 80
L2 TOB + C-30 10 80 80 80
L3 TOB + C-30 10 80 40 80
L1 C-30 10 10 10 10
L2 C-30 10 10 10 10
L3 C-30 10 10 10 10
a

L1, lineage 1; L2, lineage 2; L3, lineage 3; TOB, treatment with tobramycin alone; C-30, treatment with the QSI C-30 alone; TOB + C-30, treatment with both together.